Bio Pharma Dive
MAY 14, 2021
The biotech's treatment is part of a wave of new treatments meant to mimic the effects of natural killer cell transplants in leukemia, though analysts remain skeptical.
World of DTC Marketing
MAY 14, 2021
THOUGHT: I love working in the pharma industry. Yes, I have been critical of the industry because I believe there is too much focus on pleasing Wall Street, yet I believe that there are some really good people starting to climb the ladder and that soon we’ll see some really substantial changes. Believe in what we can do together. One change in the workplace is that employees want more of a say about their company when it comes to social and moral issues.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
MAY 14, 2021
The results are a setback for Biogen, which spent $800 million two years ago to acquire the treatment's developer, Nightstar Therapeutics.
BioSpace
MAY 14, 2021
Cellino’s unique blend of lasers and machine learning is transforming the manufacture of autologous stem cell therapies from an inconsistent hand-crafted endeavor to a scalable, efficient, closed-loop, modern process.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
BioPharma Reporter
MAY 14, 2021
Moderna has agreed to provide 15m doses of its updated variant COVID-19 vaccine to Australia, providing a boost to its efforts to generate ongoing revenues from its coronavirus work.
BioSpace
MAY 14, 2021
A study, published recently in the New England Journal of Medicine, demonstrated no obvious safety signals among pregnant persons who received the mRNA vaccines.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioSpace
MAY 14, 2021
PerkinElmer expands its presence with the acquisition of Nexcelom, which would allow the company to expand global efforts to accelerate time to target and time to market for novel therapeutics.
pharmaphorum
MAY 14, 2021
NICE has issued a final “no” to Bristol-Myers Squibb’s oral MS drug Zeposia (ozanimod), in a decision that prevents access for patients in England and Wales. This ruling means that there will be a divide in access to Zeposia in the UK, after the Scottish Medicines Consortium allowed funding in February for the drug in patients eligible or asking for an oral treatment.
BioSpace
MAY 14, 2021
Pfizer’s clinical trials diversity report showed the disproportionate way the virus impacted minority communities in the U.S., increasing the calls for racial and ethnic diversity in clinical studies.
Pharma Marketing Network
MAY 14, 2021
[link]. The post DarshanTalks: How To Build a Trusted Workforce</br> – May 14, 2021 appeared first on Pharma Marketing Network.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
BioSpace
MAY 14, 2021
Life science jobs are booming in several regions around the U.S. One is the Pacific Northwest, specifically Oregon; another is the Philadelphia area. Here’s a look.
BioPharma Reporter
MAY 14, 2021
The antibody response in people aged 80+ is three and a half times greater when the second dose of the COVID-19 vaccine is administered after 12 weeks, compared to the response when the second dose is given after three weeks, according to a UK study.
pharmaphorum
MAY 14, 2021
In this episode of our Health Innovators series, Paul Tunnah is joined by Teresa Arroyo-Gallego, chief data scientist at artificial intelligence technology company nQ Medical. As a researcher in the biomedical engineering lab of the Massachusetts Institute of Technology (MIT), Teresa leads a team developing the neuroQWERTY technology to detect early signs of motor decline in diseases like Parkinson’s by monitoring how people type on their phones or computers. nQ Medical are hoping the technology
Scienmag
MAY 14, 2021
Findings provide baseline number of brain cells likely needed for complex behaviors Credit: Joshua Raji and Christopher Potter, Johns Hopkins Medicine. In research made possible when COVID-19 sidelined other research projects, scientists at Johns Hopkins Medicine meticulously counted brain cells in fruit flies and three species of mosquitos, revealing a number that would surprise many […].
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
BioSpace
MAY 14, 2021
The help wanted signs are up across the biopharma industry. Companies are opening and expanding facilities, which is good news for job seekers.
Scienmag
MAY 14, 2021
Hydrogels merge two physical forms of the same seaweed material for strength, flexibility Credit: Orlin Velev, NC State University 3D-printable gels with improved and highly controlled properties can be created by merging micro- and nano-sized networks of the same materials harnessed from seaweed, according to new research from North Carolina State University.
BioSpace
MAY 14, 2021
Overall, the researchers claim this “Disinformation Dozen” generate approximately 65% of the anti-vaccine misinformation on these platforms.
Scienmag
MAY 14, 2021
‘Artificial retina’ created using a biomedical printing press Credit: University of Sydney A researcher at the University of Sydney is developing a printable device that acts like a retina and could one day restore sight to blind people. Dr Matthew Griffith, from the Australian Centre for Microscopy & Microanalysis and the School of Aerospace, Mechanical […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharma Times
MAY 14, 2021
Vaccine induced strong immune responses in a rat model during preclinical testing
Scienmag
MAY 14, 2021
Credit: The authors Extracting hydrogen from water through electrolysis offers a promising route for increasing the production of hydrogen, a clean and environmentally friendly fuel. But one major challenge of water electrolysis is the sluggish reaction of oxygen at the anode, known as the oxygen evolution reaction (OER). A collaboration between researchers at Hunan University […].
XTalks
MAY 14, 2021
If you’ve spent some time working as a clinical research associate (CRA) and are looking to advance your career, you might be wondering where to start. For ambitious and dedicated CRAs, fast tracking your career could be more feasible than you think. Here are three ways to advance your career in clinical research. To learn more about what it takes to progress from a CRA to a project manager or clinical trial manager position in less than two years, register for this free webinar hosted by trial
Scienmag
MAY 14, 2021
Credit: Vanderbilt University Medical Center People with a high polygenic risk score for colorectal cancer could benefit more at preventing the disease by leading healthy lifestyles than those at lower genetic risk, according to a study by Vanderbilt researchers published in the April issue of The American Journal of Clinical Nutrition. Analyzing data from participants […].
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Pharma Times
MAY 14, 2021
Drug candidate is being evaluated for the treatment of Alzheimer's disease psychosis
Scienmag
MAY 14, 2021
Approach opens a new avenue to study the biology of acute leukemia and for the development of new drugs Credit: Grembecka / Cierpicki Labs The protein made by the ASH1L gene plays a key role in the development of acute leukemia, along with other diseases. The ASH1L protein, however, has been challenging to target therapeutically. […].
pharmaphorum
MAY 14, 2021
Swiss biotech MoonLake Immunotherapeutics has emerged with what it hopes is one of the hottest drugs in inflammatory diseases, sonelokimab. In an interview with pharmaphorum’s news editor Richard Staines, chief operating officer Arnout Ploos van Amstel revealed how the biotech and its “mystery CEO” managed to swoop for the drug ahead of big pharma rivals.
Scienmag
MAY 14, 2021
Credit: Camila dos Santos/dos Santos lab, CSHL/2021 What if you could predict which cells might become cancerous? Breast tissue changes dramatically throughout a woman’s life, so finding markers for sudden changes that can lead to cancer is especially difficult. Cold Spring Harbor Laboratory (CSHL) Associate Professor Camila dos Santos and her team identified and cataloged […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
pharmaphorum
MAY 14, 2021
NICE has a global reputation as a pioneering HTA – but is that influence at risk now that the UK has left the EU? Experts from ICON give us their views on the past, present and future of NICE’s standing on the world stage. This article appears in our digital magazine, Deep Dive: Market Access 2021. Read below for a preview: One of the earliest and most pronounced impacts of the UK’s vote to leave the European Union was the loss of the European Medicines Agency (EMA).
Scienmag
MAY 14, 2021
to support management/sharing of research data among Japanese academic institutions nationwide Credit: © National Institute of Informatics NII developed GakuNin RDM in response to the Japanese government’s policy on science and technology, as well as the international trend toward open science. The GakuNin RDM service supports researchers’ data management, from daily research activities in the […].
Pharma Times
MAY 14, 2021
Cost-effectiveness watchdog recommends first immunotherapy for unresectable advanced oesophageal cancer
Scienmag
MAY 14, 2021
Anthocerotibacter panamensis, a newly discovered species of cyanobacteria, can help researchers study the dawn of oxygenic photosynthesis Credit: Fay-Wei Li ITHACA, NY, May 13, 2021 — Cyanobacteria are one of the unsung heroes of life on Earth. They first evolved to perform photosynthesis about 2.4 billion years ago, pumping tons of oxygen into the atmosphere […].
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
356 
Let's personalize your content